Insights into Doublet Therapy and Clinical Trial Takeaways for Metastatic Prostate Cancer Treatment : Episode 1
Opinion
Video
Therapeutic Combination Therapies for Metastatic Prostate Cancer
Author(s):
Fred Saad, CQ, MD, FRCS, FCAHS, discusses how combining therapies like androgen receptor–targeted agents, androgen deprivation therapy, and docetaxel can potentially improve outcomes for metastatic prostate cancer patients, with treatment selection influenced by factors such as disease volume and risk level.
The above content is prompted by the following:
- Discuss some therapeutic combinations for metastatic prostate cancer.
- What is the general rationale for using combination therapy (eg, androgen receptor–targeted agent and/or an androgen deprivation therapy with docetaxel)?
- How do disease volume and level of disease risk affect selection of therapy?
Related Videos
Related Content
